Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17β-estradiol-stimulated mammary tumorigenesis

Anticancer Research

Volumn 25, Issue 1 A, 2005, Pages 369-375

  Zhang, Xintian ^a   Shen, Peng ^b   Coleman, Megan ^a   Zou, Wei ^c   Loggie, Brian W ^a   Smith, Leia M ^d   Wang, ZhaoYi ^a  

^a CREIGHTON UNIVERSITY   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c LIAONING NORMAL UNIVERSITY   (China)

^d SEATTLE GENETICS INC   (United States)

Author keywords

Breast cancer; Caveolin 1; Estrogen receptor; Estrogen signaling

Indexed keywords

BETA CYCLODEXTRIN; BETA METHYL CYCLODEXTRIN; CAVEOLIN 1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; CANCER CELL CULTURE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; BETA-CYCLODEXTRINS; BREAST; BREAST NEOPLASMS; CAVEOLIN 1; CAVEOLINS; CELL GROWTH PROCESSES; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE;

EID: 16344386431     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Clemons M and Goss P: Estrogen and the risk of breast cancer. N Engl J Med 344: 276-285, 2001.
2. Preston-Martin S, Pike MC, Ross RK, Jones PA and Henderson BE: Increased cell division as a cause of human cancer. Cancer Res 50: 7415-7421, 1990.
3. Evans RM: The steroid and thyroid homone receptor superfamily. Science 240: 8890-895, 1998.
4. Beato M, Herrlich P and Schutz G: Steroid-hormone receptors: many actors in search of a plot. Cell 83: 851-857, 1995.
5. Khan SA, Rogers MA, Obando JA and Tamsen A: Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54: 993-997, 1994.
6. Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MP, Sibson DR and Sloane JP: Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Patholl 155: 1811-1815, 1999.
7. Clarke RB, Howell A, Potten CS and Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991, 1997.
8. Liu P, Rudick M and Anderson RG: Multiple functions of caveolin-1. J Biolog Chem 277: 41295-41298, 2002.
9. Okamoto T, Schlegel A, Scherer PE and Lisanti MP: Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biolog Chem 275: 5419-5422, 1998.
10. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG and Lisanti MP: Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biolog Chem 275: 20448-20455, 1998.
11. Razani B, Schlegel A, Liu J and Lisanti MP: Caveolin-1, a putative tumor suppressor gene. Biochem Soc Transactions 29: 494-499, 2001.
12. Engelman JA, Zhang XL and Lisanti MP: Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 448: 221-230, 1999.
13. Hatanaka M, Maeda T, Ikemoto T, Mori H, Seya T and Shimizu A: Expression of caveolin-1 in human T cell leukemia cell lines. Biochem Biophys Res Commun 255: 382-387, 1998.
14. Lee SW, Reimer CL, Oh P, Campbell DB and Schnitzer JE: Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16: 1391-1397, 1998.
15. Fiucci G, Ravid D, Reich R and Liscovitch M: Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21: 2365-2375, 2002.
16. Zhang W, Razani B, Altschuler Y, Bouzahzah B, Mostov K, Pestell R and Lisanti MP: Caveolin-1 inhibits epidermal growth factor-stimulated lemellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J Biolog Chem 275: 20717-20725, 2000.
17. Bender FC, Reymond MA, Bron C and Quest AFG: Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60: 5870-5878, 2000.
18. Bagnoli M, Tomassetti A, Figini M, Flati S, Dolo V, Canevari S and Miotti S: Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression. Oncogene 19: 4754-4763, 2000.
19. Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A and Reich R: Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study. Gynecol Oncol 81: 166-171, 2001.
20. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM, and Schneider U: Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158: 833-839, 2001.
21. Racine C, Belanger M, Hirabayashi H, Boucher M, Chakir J and Couet J: Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem Biophys Res Commun 255: 580-586, 1999.
22. Koleske AJ, Baltimore D and Lisanti MP: Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92: 1381-1385, 1995.
23. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T and Lisanti MP: Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biolog Chem 272: 16374-16381, 1997.
24. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG and Lisanti MP: Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648, 1998.
25. Zou W, McDaneld L and Smith LM: Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells. Anticancer Res 23: 4581-4586, 2003.
26. Shekhar MPV, Chen ML, Werdell J, Heppner GH, Miller FR and Christman JK: Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer. Int J Oncol 13: 907-915, 1998.
27. Shekhar MPV, Nangia-Makker P, Wolman SR, Tait L, Heppner GH and Visscher DW: Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Pathl 152: 1129-1132, 1998.
28. Kranenburg O, Verlaan I and Moolenaar WH: Regulating c-Ras function: cholesterol depletion affects caveolin association, GTP loading, and signaling. Curr Biol 11: 1880-1884, 2001.
29. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P and Chambon P: Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7 Biochem Soc Trans 12: 2861-2878, 1984.
30. Sager R: RNA genetics of breast cancer: masoin as a paradigm. Cold Spring Harbor Symp. Quant Biol 59: 537-546, 1994.
31. Hayashi K, Matsuda S, Machida K, Yamamoto T and Hamaguchi M: Invasion activating caveolin-1 mutatic. Cancer Res 61: 2361-2364, 2001.
32. Lee H, Park DS, Razani B, Russell RG, Pestell RG and Lisanti MP: Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol 161: 1357-1369, 2002.
33. Williams TM, Cheung MW, Park DS, Razani Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG and Lisanti MP: Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol Biol Cell 14: 1027-1042, 2003.
34. Lupulescu A: Estrogen use and cancer incidence: a review. Cancer Invest 13: 287-295, 1995.
35. Kushner PJ, Hort E, Shine J, Baxter JD and Greene GL: Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4: 1465-1473, 1990.
36. Touitou I, Mathieu M and Rochefort H: Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth. Biochem Biophys Res Commun 769: 109-115, 1990.
37. Pilat MJ, Christman JK and Brooks SC: Characterization of the estrogen receptor transfected MCF1A breast cell line 139B6. Breast Cancer Res Treat 37: 253-266, 1996.
38. Jiang SY and Jordan VC: Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84: 580-591, 1992.
39. Razandi M, Oh P, Pedram A, Schnitzer J and Levin ER: ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16: 100-115, 2002.
40. Zschocke J, Manthey D, Bayatti N, van der Burg B, Goodenough S and Behl C: Estrogen receptor amediated silencing of caveolin gene expression in neuronal cells. J Biolog Chem 277: 38772-38780, 2002.
41. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG and Lisanti MP: Caveolin-1 potentiates estrogen receptor a (ERa) signaling. J Biol Chem 274: 33551-33556, 1999.
42. Schlegel A, Wang C, Pestell RG and Lisanti MP: Ligand-independent activation of oestrogen receptor α by caveolin-1. Biochem J 359: 203-210, 1999.